Argenx
ARGX
#442
Rank
ยฃ39.64 B
Marketcap
ยฃ636.63
Share price
-3.07%
Change (1 day)
27.07%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Earnings for Argenx (ARGX)

Earnings in 2025 (TTM): ยฃ0.72 Billion

According to Argenx 's latest financial reports the company's current earnings are ยฃ3.60 Billion. In 2024 the company made an earning of ยฃ63.72 Million, an increase over its 2023 earnings that were of -ยฃ0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Argenx from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) ยฃ0.72 B1032.45%
2024 ยฃ63.72 M-127.97%
2023 -ยฃ0.23 Billion-58.25%
2022 -ยฃ0.55 Billion80.17%
2021 -ยฃ0.31 Billion
2019 -ยฃ0.15 Billion124.86%
2018 -ยฃ66.16 Million131.81%
2017 -ยฃ28.54 Million
2015 -ยฃ13.78 Million
2013 -ยฃ8.34 Million